[des-Arg9]bradykinin (Human) [2842]
[des-Arg9]bradykinin (Human)
| SMILES |
N=C(N)NCCCC(N)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)O |
| InChIKey |
VCEHWDBVPZFHAG-UHFFFAOYSA-N |
| Sequence |
RPPGFSPF |
| HELM |
PEPTIDE1{(R,[dR]).(P,[dP]).(P,[dP]).G.(F,[dF]).(S,[dS]).(P,[dP]).(F,[dF])}$$$$V2.0 |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Log P |
None |
| Molecular weight (Da) |
None |
No bioactivity data available.
[des-Arg9]bradykinin (Human)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.